Drug Trial Radar · NCT04710576
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Last checked: Nov 20, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
296
Planned (sponsor's estimate)
Start
Mar 4, 2021
Primary completion
Apr 7, 2023
Study completion Sep 2027
Sponsor
- Lead sponsor
- Syndax PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jan 14, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2 study to evaluate the efficacy, safety, and tolerability of axatilimab at 3 different dose levels in participants with recurrent or refractory active chronic graft versus host disease (cGVHD) who have received at least 2 prior lines of systemic therapy.
Conditions
- Chronic Graft-versus-host-disease
Interventions
AxatilimabDrug
Axatilimab is a high-affinity antibody targeting the colony stimulating factor 1 receptor (CSF-1R). CSF-1R signaling has been demonstrated in nonclinical studies to be the key regulatory pathway involved in the expansion and infiltration of donor-derived macrophages that mediate the disease processes involved in cGVHD.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response Rate (ORR) in the First 6 Cycles as Defined by the 2014 NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease (cGVHD)Time frame: First 6 cycles (up to Cycle 7 Day 1; each cycle = 4 weeks)
Locations
121 sites in 16 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham - Children's of Alabama
Birmingham, Alabama · Completed
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
City of Hope
Duarte, California · Active not recruiting
University of Southern California Norris Comprehensive Cancer Center
Los Angeles, California · Recruiting
University of California, Los Angeles (UCLA) - Medical Center
Los Angeles, California · Completed
Stanford Cancer Center
Stanford, California · Active not recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Active not recruiting
University of Florida (UF)
Gainesville, Florida · Completed
Mayo Clinic - Jacksonville
Jacksonville, Florida · Active not recruiting
University of Miami
Miami, Florida · Recruiting
AdventHealth Orlando
Orlando, Florida · Completed
Moffitt
Tampa, Florida · Active not recruiting
Emory University
Atlanta, Georgia · Recruiting
Northside Hospital
Atlanta, Georgia · Active not recruiting
The University of Chicago Medical Center (UCMC)
Chicago, Illinois · Recruiting
Indiana University Health Melvin and Bren Simon Cancer Center
Indianapolis, Indiana · Active not recruiting
Franciscan Health Indianapolis
Indianapolis, Indiana · Completed
Tulane University Medical Center
New Orleans, Louisiana · Completed
Johns Hopkins Kimmel Cancer Center
Baltimore, Maryland · Completed
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts · Active not recruiting
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts · Active not recruiting
University of Michigan
Ann Arbor, Michigan · Active not recruiting
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan · Recruiting
Henry Ford Hospital
Detroit, Michigan · Completed
University of Minnesota
Minneapolis, Minnesota · Completed
Mayo Clinic - Rochester
Rochester, Minnesota · Active not recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey · Active not recruiting
Weill Medical College of Cornell University
New York, New York · Active not recruiting
Stony Brook University Medical Center
Stony Brook, New York · Active not recruiting
Wake Forest
Winston-Salem, North Carolina · Completed
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Completed
University Hospitals Cleveland Medical Center
Cleveland, Ohio · Completed
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
The Cleveland Clinic Foundation
Lyndhurst, Ohio · Active not recruiting
University of Oklahoma - Health Sciences Center
Oklahoma City, Oklahoma · Active not recruiting
Oregon Health & Science University
Portland, Oregon · Recruiting
University of Pittsburgh Medical Center - Hillman Cancer Center
Pittsburgh, Pennsylvania · Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Active not recruiting
Showing 40 of 121 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.